In a patient with moderate aortic regurgitation on echocardiogram and an ejection fraction of 55%, what are the next management steps?

Management of Moderate Aortic Regurgitation with EF 55%

For moderate AR with preserved EF (55%), you should initiate regular surveillance with clinical assessment and repeat echocardiography every 1-2 years, while confirming the patient remains truly asymptomatic. 1, 2

Stage Classification and Current Status

Your patient falls into Stage B chronic AR according to ACC/AHA guidelines 1:

• Progressive AR (moderate severity)
• Normal LV systolic function (EF 55%)
• No symptoms
• Does not yet meet criteria for intervention

Immediate Next Steps

1. Confirm Asymptomatic Status

• Directly question about:
  • Dyspnea on exertion or at rest
  • Exercise intolerance or reduced functional capacity
  • Chest discomfort
  • Palpitations
• Consider exercise stress testing if symptom status is uncertain—this is reasonable per guidelines to objectively confirm the patient can exercise without symptoms 1

2. Verify Echo Measurements

Ensure the following parameters were assessed on the current echo 1:

• LV dimensions: LVESD (should be <50 mm or <25 mm/m²)
• LV end-diastolic dimension: Should be documented
• Quantitative AR parameters:
  • Vena contracta (moderate = 0.3-0.6 cm)
  • Regurgitant volume (moderate = 30-59 mL/beat)
  • Regurgitant fraction (moderate = 30-49%)
  • ERO (moderate = 0.10-0.29 cm²)

3. Assess Etiology

Identify the cause of AR to guide surveillance 1:

• Bicuspid aortic valve or other congenital anomaly
• Dilated aortic sinuses/ascending aorta (may need aortic imaging)
• Rheumatic disease
• Calcific degeneration
• Previous endocarditis

Surveillance Protocol

Follow-up schedule for moderate AR with normal LV function 2:

• Clinical evaluation: Every 1-2 years
• Repeat TTE: Every 1-2 years
• More frequent monitoring (every 3-6 months) if:
  • LV dimensions begin to increase
  • Any decline in EF is detected
  • New symptoms develop

Medical Management

No routine vasodilator therapy is indicated for asymptomatic moderate AR with normal LV function 1. Medical therapy is reserved for:

• Severe AR (not your patient)
• Patients with contraindications to surgery
• Hypertension management if present (treat to normal BP targets)

Red Flags Requiring Intervention

Surgery is NOT indicated now, but monitor for progression to these thresholds 1, 2:

Surgical Indications (when AR becomes severe):

• Symptoms develop (dyspnea, angina, heart failure)
• EF drops to ≤55% (or <50% per ESC)
• LVESD increases to >50 mm (or >25 mm/m²)
• LVEDD reaches >65 mm
• Patient requires cardiac surgery for another indication

Common Pitfalls

1. Don't assume asymptomatic status—patients often unconsciously reduce activity. Exercise testing objectively confirms functional capacity 1

2. Don't delay imaging if clinical change occurs—even subtle symptom development warrants repeat echo within 3 months

3. Don't miss progression from moderate to severe AR—the transition can be gradual, requiring serial quantitative measurements, not just qualitative jet assessment

4. Don't forget aortic root evaluation—if AR is due to aortic root dilation, the aorta itself may require intervention even before the valve does 1

Documentation for Future Reference

Establish baseline measurements now for comparison:

• Exact LVEF, LVESD, LVEDD
• Quantitative AR parameters (not just "moderate")
• Functional class (NYHA I)
• Exercise capacity if tested

This creates a clear trajectory for detecting progression toward surgical thresholds 2, 3.